Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan.

[1]  C. Chiu,et al.  Clonal spread of macrolide-resistant Mycoplasma pneumoniae sequence type-3 and type-17 with recombination on non-P1 adhesin among children in Taiwan. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  Steven D. Dallas,et al.  Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018 , 2020, Journal of Clinical Microbiology.

[3]  Ting-Yu Yen,et al.  Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan. , 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  Luan-Yin Chang,et al.  Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter? , 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[5]  H. Yang.  Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children , 2019, Korean journal of pediatrics.

[6]  Hyunju Lee,et al.  Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children , 2018, Expert review of anti-infective therapy.

[7]  Wei‐Ju Lee,et al.  Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children. , 2017, Pediatrics and neonatology.

[8]  Mitchell F. Balish,et al.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond , 2017, Clinical Microbiology Reviews.

[9]  Zhimin Chen,et al.  Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children , 2016, Scientific Reports.

[10]  S. Pereyre,et al.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment , 2016, Front. Microbiol..

[11]  Zhimin Chen,et al.  The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children , 2016, PloS one.

[12]  T. Ariga,et al.  Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan. , 2016, Japanese journal of infectious diseases.

[13]  Yhu-Chering Huang,et al.  Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[14]  Xiaobo Zhang,et al.  Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children , 2015, Respiratory Care.

[15]  D. Keše,et al.  Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  Zhengrong Chen,et al.  Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[17]  Xiang-zhi Li,et al.  Macrolide-Resistant Mycoplasma pneumoniae in Adults in Zhejiang, China , 2014, Antimicrobial Agents and Chemotherapy.

[18]  Maureen H Diaz,et al.  Investigations of Mycoplasma pneumoniae Infections in the United States: Trends in Molecular Typing and Macrolide Resistance from 2006 to 2013 , 2014, Journal of Clinical Microbiology.

[19]  E. Liu,et al.  Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children , 2014, Pediatric pulmonology.

[20]  Yhu-Chering Huang,et al.  Epidemiology and clinical manifestations of children with macrolide‐resistant Mycoplasma pneumoniae pneumonia in Taiwan , 2013, Pediatric pulmonology.

[21]  Y. Nishizawa,et al.  Nationwide Surveillance of Macrolide-Resistant Mycoplasma pneumoniae Infection in Pediatric Patients , 2013, Antimicrobial Agents and Chemotherapy.

[22]  K. Tsao,et al.  Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[23]  S. Esposito,et al.  Clinical Relevance of Mycoplasma pneumoniae Macrolide Resistance in Children , 2012, Journal of Clinical Microbiology.

[24]  C. Chiu,et al.  Etiology of Community-acquired Pneumonia in Hospitalized Children in Northern Taiwan , 2012, The Pediatric infectious disease journal.

[25]  D. Engelhard,et al.  Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. , 2011, Emerging infectious diseases.

[26]  M. Morozumi,et al.  Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[27]  M. Matsuoka,et al.  Clinical Evaluation of Macrolide-Resistant Mycoplasma pneumoniae , 2006, Antimicrobial Agents and Chemotherapy.

[28]  M. Morozumi,et al.  Emergence of Macrolide-Resistant Mycoplasma pneumoniae with a 23S rRNA Gene Mutation , 2005, Antimicrobial Agents and Chemotherapy.